IBDEI1ML ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25973,2)
 ;;=^5062848
 ;;^UTILITY(U,$J,358.3,25974,0)
 ;;=N81.6^^107^1227^97
 ;;^UTILITY(U,$J,358.3,25974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25974,1,3,0)
 ;;=3^Rectocele w/o Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,25974,1,4,0)
 ;;=4^N81.6
 ;;^UTILITY(U,$J,358.3,25974,2)
 ;;=^259590
 ;;^UTILITY(U,$J,358.3,25975,0)
 ;;=Z12.39^^107^1227^101
 ;;^UTILITY(U,$J,358.3,25975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25975,1,3,0)
 ;;=3^Screening for Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,25975,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,25975,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,25976,0)
 ;;=Z12.72^^107^1227^102
 ;;^UTILITY(U,$J,358.3,25976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25976,1,3,0)
 ;;=3^Screening for Malig Neop of Vagina
 ;;^UTILITY(U,$J,358.3,25976,1,4,0)
 ;;=4^Z12.72
 ;;^UTILITY(U,$J,358.3,25976,2)
 ;;=^5062691
 ;;^UTILITY(U,$J,358.3,25977,0)
 ;;=Z12.31^^107^1227^100
 ;;^UTILITY(U,$J,358.3,25977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25977,1,3,0)
 ;;=3^Screening Mammogram for Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,25977,1,4,0)
 ;;=4^Z12.31
 ;;^UTILITY(U,$J,358.3,25977,2)
 ;;=^5062685
 ;;^UTILITY(U,$J,358.3,25978,0)
 ;;=A59.01^^107^1227^109
 ;;^UTILITY(U,$J,358.3,25978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25978,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,25978,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,25978,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,25979,0)
 ;;=N81.3^^107^1227^110
 ;;^UTILITY(U,$J,358.3,25979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25979,1,3,0)
 ;;=3^Uterovaginal Prolapse,Complete
 ;;^UTILITY(U,$J,358.3,25979,1,4,0)
 ;;=4^N81.3
 ;;^UTILITY(U,$J,358.3,25979,2)
 ;;=^5015840
 ;;^UTILITY(U,$J,358.3,25980,0)
 ;;=N81.2^^107^1227^111
 ;;^UTILITY(U,$J,358.3,25980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25980,1,3,0)
 ;;=3^Uterovaginal Prolapse,Incomplete
 ;;^UTILITY(U,$J,358.3,25980,1,4,0)
 ;;=4^N81.2
 ;;^UTILITY(U,$J,358.3,25980,2)
 ;;=^5015839
 ;;^UTILITY(U,$J,358.3,25981,0)
 ;;=N76.0^^107^1227^117
 ;;^UTILITY(U,$J,358.3,25981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25981,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,25981,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,25981,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,25982,0)
 ;;=N95.2^^107^1227^118
 ;;^UTILITY(U,$J,358.3,25982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25982,1,3,0)
 ;;=3^Vaginitis,Atrophic,Postmenopausal
 ;;^UTILITY(U,$J,358.3,25982,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,25982,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,25983,0)
 ;;=N76.1^^107^1227^119
 ;;^UTILITY(U,$J,358.3,25983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25983,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,25983,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,25983,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,25984,0)
 ;;=N94.810^^107^1227^121
 ;;^UTILITY(U,$J,358.3,25984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25984,1,3,0)
 ;;=3^Vulvar Vestibulitis
 ;;^UTILITY(U,$J,358.3,25984,1,4,0)
 ;;=4^N94.810
 ;;^UTILITY(U,$J,358.3,25984,2)
 ;;=^336618
 ;;^UTILITY(U,$J,358.3,25985,0)
 ;;=N76.2^^107^1227^122
 ;;^UTILITY(U,$J,358.3,25985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25985,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,25985,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,25985,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,25986,0)
 ;;=N94.818^^107^1227^120
